A 35-year-old man from Mumbai presents with a 4-week history of painful perianal lesions and inguinal lymphadenopathy. He reports receptive anal intercourse. Physical examination reveals multiple verrucous, hyperkeratotic lesions around the anus with central ulceration. PCR testing confirms HPV-16 infection. He is otherwise immunocompetent (CD4 count 650 cells/μL). Which of the following best explains why this patient developed anogenital HPV disease despite having a normal CD4 count?

## HPV Infection and Immune Control: Local vs. Systemic Immunity ### Pathogenesis of Anogenital HPV Disease **Key Point:** While systemic CD4+ T-cell immunity is important for controlling HPV, anogenital HPV disease is primarily driven by local mucosal infection and viral persistence. Clinical manifestation does not require severe systemic immunosuppression. ### Immunity in HPV Infection: A Two-Tier System | Immune Component | Role in HPV Control | Clinical Relevance | |---|---|---| | **Mucosal immunity (IgA, local T cells)** | Primary defense against initial infection and reactivation | Defects lead to persistent infection and disease | | **Systemic CD4+ T cells** | Clearance of established infection; prevention of progression | Critical when CD4 <200 cells/μL; less critical at normal counts | | **Innate immunity (NK cells, TLRs)** | Early response to viral antigens | Contributes to local control | **High-Yield:** Anogenital HPV disease (condylomata acuminata, CIN, anal cancer) occurs in immunocompetent individuals with normal CD4 counts. The disease is driven by **local viral persistence**, not systemic immunodeficiency. ### Why This Patient Developed Disease Despite Normal CD4 1. **Local mucosal infection** → HPV-16 infects basal epithelial cells in the anogenital region 2. **Weak local immune response** → Mucosal IgA and local T-cell response may be insufficient to clear the virus 3. **Persistent viral replication** → Chronic infection leads to epithelial proliferation → verrucous lesions 4. **Systemic immunity intact** → CD4 count of 650 cells/μL is adequate but does not prevent local disease **Clinical Pearl:** Condylomata acuminata (genital warts) are the most common manifestation of HPV infection in immunocompetent individuals. They are caused by low-risk HPV types (6, 11) and high-risk types (16, 18). The presence of HPV-16 in this patient increases the risk of malignant transformation (anal cancer). ### Distinction: Immunocompetent vs. Immunocompromised - **Immunocompetent (CD4 >500):** Anogenital warts, CIN, anal intraepithelial neoplasia (AIN) — local disease - **Severely immunocompromised (CD4 <200):** Extensive anogenital disease, rapid progression to invasive cancer, multifocal involvement **Mnemonic:** **"Local Lesion, Local Immunity"** — HPV disease at mucosal sites depends more on local immune control than systemic CD4 count. ### Why Other Options Are Wrong - **Option A (CD4 <200 required):** Anogenital HPV disease occurs at all CD4 counts; it is not a threshold-dependent opportunistic infection like PCP or CMV. - **Option C (inherent pathogenicity):** HPV-16 is oncogenic but requires immune evasion; it does not cause disease "regardless of immune status." - **Option D (occult HIV):** The CD4 count of 650 is normal; there is no clinical or immunological evidence of HIV. [cite:Harrison 21e Ch 188; Robbins 10e Ch 7]